In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

Kansas legislators, Republican and Democrat, are frustrated bills to help control prescription drug prices are blocked by GOP ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

Illinois is facing an intense battle over a federal program requiring drug manufacturers to sell deeply discounted ...

Dartmouth hospital CFO details 340B designation risk and strategic partnership to safeguard federal program participation at ...

(The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to a ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...